Dr. Perl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10201 Grosvenor Pl
Apt 901
Rockville, MD 20852Phone+1 240-423-7348
Education & Training
- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2008
- Ben Gurion University of the NegevClass of 1999
Certifications & Licensure
- MD State Medical License 2007 - 2025
Clinical Trials
- Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Start of enrollment: 2009 Aug 06
- Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 3 citationsCombination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.Hiddo J L Heerspink, Austin G Stack, Robert Terkeltaub, Niels Jongs, Lesley A Inker
Journal of the American Society of Nephrology. 2024-05-01 - 2 citationsVerinurad does not prolong QTc interval: a thorough QT study using concentration-QTc modelling.Joanna Parkinson, Corina Dota, Christian Källgren, Christer Gottfridsson, Magnus Bjursell
British Journal of Clinical Pharmacology. 2023-06-01 - 7 citationsRationale, design, demographics, and baseline characteristics of the randomised, controlled, phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chr...Hiddo J.L. Heerspink, Austin G. Stack, Robert Terkeltaub, Tom Greene, Lesley A. Inker
Nephrology, Dialysis, Transplantation. 2021-08-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: